CIK 0001754068
- Non-accelerated filer
- Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831971007
- Phone
- +1 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 25 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-23 | Brenner Malcolm Director | Sale | −1,801 | $40.40 | $73K | 968,819 |
| 2021-02-23 | Brenner Malcolm Director | Sale | −200 | $41.19 | $8K | 968,619 |
| 2021-02-22 | Vera Juan Director | Sale | −2,891 | $41.58 | $120K | 2,424,044 |
| 2021-02-22 | Vera Juan Director | Sale | −11,050 | $42.80 | $473K | 2,412,994 |
| 2021-02-22 | Vera Juan Director | Sale | −380 | $43.40 | $16K | 2,412,614 |
| 2021-02-22 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −600 | $41.53 | $25K | 498,480 |
| 2021-02-22 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −2,200 | $42.82 | $94K | 496,280 |
| 2021-02-22 | Leen Ann M. Chief Scientific Officer | Sale | −1,200 | $41.54 | $50K | 2,480,390 |
| 2021-02-22 | Leen Ann M. Chief Scientific Officer | Sale | −4,506 | $42.84 | $193K | 2,475,884 |
| 2021-02-22 | Hagen Brett R Chief Accounting Officer | Sale | −800 | $43.14 | $35K | 64,765 |
| 2021-02-22 | Brenner Malcolm Director | Sale | −2,334 | $41.58 | $97K | 986,197 |
| 2021-02-22 | Brenner Malcolm Director | Sale | −8,779 | $42.80 | $376K | 977,418 |
| 2021-02-22 | Brenner Malcolm Director | Sale | −310 | $43.38 | $13K | 977,108 |
| 2021-02-19 | Vera Juan Director | Sale | −13,233 | $41.79 | $553K | 2,426,935 |
| 2021-02-19 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −4,165 | $41.71 | $174K | 499,080 |
| 2021-02-19 | Leen Ann M. Chief Scientific Officer | Sale | −7,541 | $41.75 | $315K | 2,481,590 |
| 2021-02-19 | Brenner Malcolm Director | Sale | −11,990 | $41.78 | $501K | 988,531 |
| 2021-02-18 | Bornstein Jeffrey S Director | Sale | −19,771 | $40.39 | $799K | 812 |
| 2021-02-18 | Bornstein Jeffrey S Director | Sale | −812 | $41.27 | $34K | 0 |
| 2021-02-18 | Leen Ann M. Chief Scientific Officer | Sale | −300 | $39.20 | $12K | 2,491,531 |
Page 22 of 27 · 527 trades